nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—CYP2C9—Disulfiram—alcohol dependence	0.186	0.538	CbGbCtD
Gliclazide—CYP2C19—Citalopram—alcohol dependence	0.159	0.461	CbGbCtD
Gliclazide—ABCC8—Inwardly rectifying K+ channels—KCNJ6—alcohol dependence	0.00752	0.0756	CbGpPWpGaD
Gliclazide—KCNJ11—Inwardly rectifying K+ channels—KCNJ6—alcohol dependence	0.00729	0.0733	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—PECR—alcohol dependence	0.00481	0.0484	CbGpPWpGaD
Gliclazide—VEGFA—adrenal cortex—alcohol dependence	0.00427	0.0646	CbGeAlD
Gliclazide—VEGFA—pancreas—alcohol dependence	0.00379	0.0573	CbGeAlD
Gliclazide—ABCC8—brainstem—alcohol dependence	0.00315	0.0476	CbGeAlD
Gliclazide—ABCC8—forebrain—alcohol dependence	0.00304	0.046	CbGeAlD
Gliclazide—ABCC8—Potassium Channels—KCNJ6—alcohol dependence	0.00297	0.0299	CbGpPWpGaD
Gliclazide—KCNJ11—Potassium Channels—KCNJ6—alcohol dependence	0.00288	0.029	CbGpPWpGaD
Gliclazide—KCNJ11—cardiovascular system—alcohol dependence	0.00279	0.0422	CbGeAlD
Gliclazide—KCNJ11—pancreas—alcohol dependence	0.00271	0.041	CbGeAlD
Gliclazide—ABCC8—cardiovascular system—alcohol dependence	0.00257	0.0389	CbGeAlD
Gliclazide—VEGFA—testis—alcohol dependence	0.00255	0.0386	CbGeAlD
Gliclazide—ABCC8—pancreas—alcohol dependence	0.0025	0.0378	CbGeAlD
Gliclazide—VEGFA—liver—alcohol dependence	0.00241	0.0365	CbGeAlD
Gliclazide—VEGFA—cerebellum—alcohol dependence	0.00236	0.0356	CbGeAlD
Gliclazide—VEGFA—Regulation of gene expression by Hypoxia-inducible Factor—EP300—alcohol dependence	0.00234	0.0236	CbGpPWpGaD
Gliclazide—ABCC8—midbrain—alcohol dependence	0.00201	0.0303	CbGeAlD
Gliclazide—VEGFA—brain—alcohol dependence	0.00191	0.0289	CbGeAlD
Gliclazide—KCNJ11—endocrine gland—alcohol dependence	0.00191	0.0289	CbGeAlD
Gliclazide—KCNJ11—nervous system—alcohol dependence	0.00179	0.0271	CbGeAlD
Gliclazide—CYP2C19—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00178	0.0179	CbGpPWpGaD
Gliclazide—ABCC8—endocrine gland—alcohol dependence	0.00176	0.0267	CbGeAlD
Gliclazide—KCNJ11—central nervous system—alcohol dependence	0.00172	0.0261	CbGeAlD
Gliclazide—KCNJ11—cerebellum—alcohol dependence	0.00169	0.0255	CbGeAlD
Gliclazide—ABCC8—testis—alcohol dependence	0.00168	0.0254	CbGeAlD
Gliclazide—ABCC8—nervous system—alcohol dependence	0.00165	0.025	CbGeAlD
Gliclazide—CYP2C9—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00162	0.0163	CbGpPWpGaD
Gliclazide—ALB—Transport of organic anions—AVP—alcohol dependence	0.0016	0.0161	CbGpPWpGaD
Gliclazide—ABCC8—central nervous system—alcohol dependence	0.00159	0.024	CbGeAlD
Gliclazide—ABCC8—cerebellum—alcohol dependence	0.00155	0.0235	CbGeAlD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—WASF2—alcohol dependence	0.0014	0.014	CbGpPWpGaD
Gliclazide—KCNJ11—brain—alcohol dependence	0.00137	0.0207	CbGeAlD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—WASF1—alcohol dependence	0.00134	0.0135	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—WASF2—alcohol dependence	0.00132	0.0133	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—KCNJ6—alcohol dependence	0.0013	0.013	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—WASF1—alcohol dependence	0.00126	0.0127	CbGpPWpGaD
Gliclazide—ABCC8—brain—alcohol dependence	0.00126	0.0191	CbGeAlD
Gliclazide—KCNJ11—Neuronal System—KCNJ6—alcohol dependence	0.00126	0.0126	CbGpPWpGaD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00126	0.0126	CbGpPWpGaD
Gliclazide—CYP2C19—digestive system—alcohol dependence	0.00123	0.0186	CbGeAlD
Gliclazide—ALB—testis—alcohol dependence	0.0012	0.0182	CbGeAlD
Gliclazide—CYP2C19—blood—alcohol dependence	0.00117	0.0177	CbGeAlD
Gliclazide—CYP2C9—cardiovascular system—alcohol dependence	0.00115	0.0174	CbGeAlD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00114	0.0115	CbGpPWpGaD
Gliclazide—ALB—liver—alcohol dependence	0.00114	0.0172	CbGeAlD
Gliclazide—CYP2C19—Xenobiotics—CYP2E1—alcohol dependence	0.0011	0.0111	CbGpPWpGaD
Gliclazide—CYP2C19—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00106	0.0107	CbGpPWpGaD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00104	0.0105	CbGpPWpGaD
Gliclazide—VEGFA—Cellular response to hypoxia—EP300—alcohol dependence	0.00104	0.0104	CbGpPWpGaD
Gliclazide—CYP2C19—endocrine gland—alcohol dependence	0.00102	0.0154	CbGeAlD
Gliclazide—CYP2C9—Xenobiotics—CYP2E1—alcohol dependence	0.00101	0.0101	CbGpPWpGaD
Gliclazide—VEGFA—EPH-Ephrin signaling—GRIN2B—alcohol dependence	0.000998	0.01	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.000971	0.00977	CbGpPWpGaD
Gliclazide—CYP2C9—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000967	0.00973	CbGpPWpGaD
Gliclazide—CYP2C9—digestive system—alcohol dependence	0.000953	0.0144	CbGeAlD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000948	0.00954	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—GABRB1—alcohol dependence	0.000937	0.00942	CbGpPWpGaD
Gliclazide—CYP2C19—liver—alcohol dependence	0.000916	0.0139	CbGeAlD
Gliclazide—KCNJ11—Neuronal System—GABRB1—alcohol dependence	0.000909	0.00914	CbGpPWpGaD
Gliclazide—CYP2C9—blood—alcohol dependence	0.000908	0.0137	CbGeAlD
Gliclazide—ALB—brain—alcohol dependence	0.000903	0.0137	CbGeAlD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000884	0.00889	CbGpPWpGaD
Gliclazide—VEGFA—HIF-2-alpha transcription factor network—EP300—alcohol dependence	0.000809	0.00814	CbGpPWpGaD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000806	0.00811	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—GABRA2—alcohol dependence	0.000797	0.00801	CbGpPWpGaD
Gliclazide—Rhinitis—Acamprosate—alcohol dependence	0.000794	0.00162	CcSEcCtD
Gliclazide—Sleep disorder—Citalopram—alcohol dependence	0.000793	0.00162	CcSEcCtD
Gliclazide—Hepatitis—Acamprosate—alcohol dependence	0.000792	0.00162	CcSEcCtD
Gliclazide—Hepatobiliary disease—Naltrexone—alcohol dependence	0.000789	0.00161	CcSEcCtD
Gliclazide—Blood alkaline phosphatase increased—Citalopram—alcohol dependence	0.000789	0.00161	CcSEcCtD
Gliclazide—Hypoaesthesia—Acamprosate—alcohol dependence	0.000788	0.00161	CcSEcCtD
Gliclazide—CYP2C9—endocrine gland—alcohol dependence	0.000788	0.0119	CbGeAlD
Gliclazide—Epistaxis—Naltrexone—alcohol dependence	0.000787	0.00161	CcSEcCtD
Gliclazide—Pharyngitis—Acamprosate—alcohol dependence	0.000786	0.00161	CcSEcCtD
Gliclazide—Sinusitis—Naltrexone—alcohol dependence	0.000783	0.0016	CcSEcCtD
Gliclazide—Polyuria—Citalopram—alcohol dependence	0.000781	0.0016	CcSEcCtD
Gliclazide—Oedema peripheral—Acamprosate—alcohol dependence	0.00078	0.00159	CcSEcCtD
Gliclazide—Gastroenteritis—Citalopram—alcohol dependence	0.000774	0.00158	CcSEcCtD
Gliclazide—KCNJ11—Neuronal System—GABRA2—alcohol dependence	0.000773	0.00777	CbGpPWpGaD
Gliclazide—Deafness—Citalopram—alcohol dependence	0.000767	0.00157	CcSEcCtD
Gliclazide—Eczema—Citalopram—alcohol dependence	0.000764	0.00156	CcSEcCtD
Gliclazide—Hepatic failure—Citalopram—alcohol dependence	0.000764	0.00156	CcSEcCtD
Gliclazide—Visual impairment—Acamprosate—alcohol dependence	0.000763	0.00156	CcSEcCtD
Gliclazide—Haemolytic anaemia—Citalopram—alcohol dependence	0.00076	0.00155	CcSEcCtD
Gliclazide—Dizziness—Disulfiram—alcohol dependence	0.000755	0.00154	CcSEcCtD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000752	0.00756	CbGpPWpGaD
Gliclazide—Hepatitis—Naltrexone—alcohol dependence	0.000749	0.00153	CcSEcCtD
Gliclazide—Injury—Citalopram—alcohol dependence	0.000747	0.00153	CcSEcCtD
Gliclazide—Pharyngitis—Naltrexone—alcohol dependence	0.000744	0.00152	CcSEcCtD
Gliclazide—Renal failure acute—Citalopram—alcohol dependence	0.000743	0.00152	CcSEcCtD
Gliclazide—Tinnitus—Acamprosate—alcohol dependence	0.000738	0.00151	CcSEcCtD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.000736	0.0074	CbGpPWpGaD
Gliclazide—Increased appetite—Citalopram—alcohol dependence	0.00073	0.00149	CcSEcCtD
Gliclazide—ALB—Selenium Micronutrient Network—GGT2—alcohol dependence	0.000729	0.00733	CbGpPWpGaD
Gliclazide—Visual disturbance—Citalopram—alcohol dependence	0.000724	0.00148	CcSEcCtD
Gliclazide—Thirst—Citalopram—alcohol dependence	0.000721	0.00147	CcSEcCtD
Gliclazide—Rash—Disulfiram—alcohol dependence	0.00072	0.00147	CcSEcCtD
Gliclazide—Headache—Disulfiram—alcohol dependence	0.000715	0.00146	CcSEcCtD
Gliclazide—Chills—Acamprosate—alcohol dependence	0.00071	0.00145	CcSEcCtD
Gliclazide—CYP2C9—liver—alcohol dependence	0.00071	0.0107	CbGeAlD
Gliclazide—Arthritis—Citalopram—alcohol dependence	0.000706	0.00144	CcSEcCtD
Gliclazide—Cardiac failure—Citalopram—alcohol dependence	0.000703	0.00144	CcSEcCtD
Gliclazide—Hypoglycaemia—Citalopram—alcohol dependence	0.000703	0.00144	CcSEcCtD
Gliclazide—Cerebrovascular accident—Citalopram—alcohol dependence	0.0007	0.00143	CcSEcCtD
Gliclazide—Eye disorder—Naltrexone—alcohol dependence	0.0007	0.00143	CcSEcCtD
Gliclazide—Tinnitus—Naltrexone—alcohol dependence	0.000699	0.00143	CcSEcCtD
Gliclazide—Mental disorder—Acamprosate—alcohol dependence	0.000694	0.00142	CcSEcCtD
Gliclazide—Malnutrition—Acamprosate—alcohol dependence	0.000689	0.00141	CcSEcCtD
Gliclazide—Hyponatraemia—Citalopram—alcohol dependence	0.000689	0.00141	CcSEcCtD
Gliclazide—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.000686	0.0014	CcSEcCtD
Gliclazide—Diplopia—Citalopram—alcohol dependence	0.000686	0.0014	CcSEcCtD
Gliclazide—Pain in extremity—Citalopram—alcohol dependence	0.000686	0.0014	CcSEcCtD
Gliclazide—Osteoarthritis—Citalopram—alcohol dependence	0.000686	0.0014	CcSEcCtD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000686	0.00689	CbGpPWpGaD
Gliclazide—Flatulence—Acamprosate—alcohol dependence	0.000679	0.00139	CcSEcCtD
Gliclazide—Tension—Acamprosate—alcohol dependence	0.000676	0.00138	CcSEcCtD
Gliclazide—CYP2C19—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000674	0.00678	CbGpPWpGaD
Gliclazide—Chills—Naltrexone—alcohol dependence	0.000672	0.00137	CcSEcCtD
Gliclazide—Nervousness—Acamprosate—alcohol dependence	0.000669	0.00137	CcSEcCtD
Gliclazide—Back pain—Acamprosate—alcohol dependence	0.000667	0.00136	CcSEcCtD
Gliclazide—CYP2C19—Biological oxidations—ADH6—alcohol dependence	0.000667	0.0067	CbGpPWpGaD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000659	0.00663	CbGpPWpGaD
Gliclazide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000658	0.00662	CbGpPWpGaD
Gliclazide—Mental disorder—Naltrexone—alcohol dependence	0.000656	0.00134	CcSEcCtD
Gliclazide—Malnutrition—Naltrexone—alcohol dependence	0.000652	0.00133	CcSEcCtD
Gliclazide—Tremor—Acamprosate—alcohol dependence	0.000646	0.00132	CcSEcCtD
Gliclazide—Flatulence—Naltrexone—alcohol dependence	0.000643	0.00131	CcSEcCtD
Gliclazide—Tension—Naltrexone—alcohol dependence	0.00064	0.00131	CcSEcCtD
Gliclazide—Ill-defined disorder—Acamprosate—alcohol dependence	0.00064	0.00131	CcSEcCtD
Gliclazide—Anaemia—Acamprosate—alcohol dependence	0.000637	0.0013	CcSEcCtD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000635	0.00639	CbGpPWpGaD
Gliclazide—Agitation—Acamprosate—alcohol dependence	0.000633	0.00129	CcSEcCtD
Gliclazide—Nervousness—Naltrexone—alcohol dependence	0.000633	0.00129	CcSEcCtD
Gliclazide—Back pain—Naltrexone—alcohol dependence	0.000631	0.00129	CcSEcCtD
Gliclazide—Angioedema—Acamprosate—alcohol dependence	0.00063	0.00129	CcSEcCtD
Gliclazide—Dry skin—Citalopram—alcohol dependence	0.000629	0.00128	CcSEcCtD
Gliclazide—Malaise—Acamprosate—alcohol dependence	0.000622	0.00127	CcSEcCtD
Gliclazide—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.000618	0.00126	CcSEcCtD
Gliclazide—Leukopenia—Acamprosate—alcohol dependence	0.000617	0.00126	CcSEcCtD
Gliclazide—Tremor—Naltrexone—alcohol dependence	0.000611	0.00125	CcSEcCtD
Gliclazide—Palpitations—Acamprosate—alcohol dependence	0.000609	0.00124	CcSEcCtD
Gliclazide—CYP2C9—Biological oxidations—ADH6—alcohol dependence	0.000608	0.00611	CbGpPWpGaD
Gliclazide—Gastritis—Citalopram—alcohol dependence	0.000607	0.00124	CcSEcCtD
Gliclazide—Loss of consciousness—Acamprosate—alcohol dependence	0.000606	0.00124	CcSEcCtD
Gliclazide—Ill-defined disorder—Naltrexone—alcohol dependence	0.000605	0.00124	CcSEcCtD
Gliclazide—Cough—Acamprosate—alcohol dependence	0.000602	0.00123	CcSEcCtD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000601	0.00605	CbGpPWpGaD
Gliclazide—Agitation—Naltrexone—alcohol dependence	0.000599	0.00122	CcSEcCtD
Gliclazide—Convulsion—Acamprosate—alcohol dependence	0.000597	0.00122	CcSEcCtD
Gliclazide—Abdominal distension—Citalopram—alcohol dependence	0.000597	0.00122	CcSEcCtD
Gliclazide—Angioedema—Naltrexone—alcohol dependence	0.000596	0.00122	CcSEcCtD
Gliclazide—Hypertension—Acamprosate—alcohol dependence	0.000595	0.00122	CcSEcCtD
Gliclazide—Asthma—Citalopram—alcohol dependence	0.000593	0.00121	CcSEcCtD
Gliclazide—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—alcohol dependence	0.000593	0.00596	CbGpPWpGaD
Gliclazide—Malaise—Naltrexone—alcohol dependence	0.000588	0.0012	CcSEcCtD
Gliclazide—Chest pain—Acamprosate—alcohol dependence	0.000587	0.0012	CcSEcCtD
Gliclazide—Myalgia—Acamprosate—alcohol dependence	0.000587	0.0012	CcSEcCtD
Gliclazide—Arthralgia—Acamprosate—alcohol dependence	0.000587	0.0012	CcSEcCtD
Gliclazide—Anxiety—Acamprosate—alcohol dependence	0.000585	0.00119	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000583	0.00119	CcSEcCtD
Gliclazide—Discomfort—Acamprosate—alcohol dependence	0.00058	0.00118	CcSEcCtD
Gliclazide—ABCC8—Neuronal System—ALDH2—alcohol dependence	0.000579	0.00582	CbGpPWpGaD
Gliclazide—Angina pectoris—Citalopram—alcohol dependence	0.000578	0.00118	CcSEcCtD
Gliclazide—Palpitations—Naltrexone—alcohol dependence	0.000576	0.00118	CcSEcCtD
Gliclazide—Dry mouth—Acamprosate—alcohol dependence	0.000574	0.00117	CcSEcCtD
Gliclazide—Loss of consciousness—Naltrexone—alcohol dependence	0.000573	0.00117	CcSEcCtD
Gliclazide—Bronchitis—Citalopram—alcohol dependence	0.00057	0.00117	CcSEcCtD
Gliclazide—Cough—Naltrexone—alcohol dependence	0.000569	0.00116	CcSEcCtD
Gliclazide—Abdominal discomfort—Citalopram—alcohol dependence	0.000569	0.00116	CcSEcCtD
Gliclazide—Confusional state—Acamprosate—alcohol dependence	0.000567	0.00116	CcSEcCtD
Gliclazide—Convulsion—Naltrexone—alcohol dependence	0.000565	0.00115	CcSEcCtD
Gliclazide—Pancytopenia—Citalopram—alcohol dependence	0.000563	0.00115	CcSEcCtD
Gliclazide—Hypertension—Naltrexone—alcohol dependence	0.000563	0.00115	CcSEcCtD
Gliclazide—KCNJ11—Neuronal System—ALDH2—alcohol dependence	0.000561	0.00565	CbGpPWpGaD
Gliclazide—Infection—Acamprosate—alcohol dependence	0.000559	0.00114	CcSEcCtD
Gliclazide—Myalgia—Naltrexone—alcohol dependence	0.000555	0.00113	CcSEcCtD
Gliclazide—Chest pain—Naltrexone—alcohol dependence	0.000555	0.00113	CcSEcCtD
Gliclazide—Arthralgia—Naltrexone—alcohol dependence	0.000555	0.00113	CcSEcCtD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000554	0.00557	CbGpPWpGaD
Gliclazide—Anxiety—Naltrexone—alcohol dependence	0.000553	0.00113	CcSEcCtD
Gliclazide—CYP2C19—Biological oxidations—ADH1A—alcohol dependence	0.000552	0.00556	CbGpPWpGaD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000551	0.00113	CcSEcCtD
Gliclazide—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000551	0.00113	CcSEcCtD
Gliclazide—Thrombocytopenia—Acamprosate—alcohol dependence	0.000551	0.00113	CcSEcCtD
Gliclazide—Tachycardia—Acamprosate—alcohol dependence	0.000549	0.00112	CcSEcCtD
Gliclazide—Discomfort—Naltrexone—alcohol dependence	0.000549	0.00112	CcSEcCtD
Gliclazide—Skin disorder—Acamprosate—alcohol dependence	0.000546	0.00112	CcSEcCtD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000546	0.00549	CbGpPWpGaD
Gliclazide—Erectile dysfunction—Citalopram—alcohol dependence	0.000546	0.00112	CcSEcCtD
Gliclazide—Hyperhidrosis—Acamprosate—alcohol dependence	0.000544	0.00111	CcSEcCtD
Gliclazide—Dry mouth—Naltrexone—alcohol dependence	0.000543	0.00111	CcSEcCtD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000543	0.00546	CbGpPWpGaD
Gliclazide—Photosensitivity reaction—Citalopram—alcohol dependence	0.000541	0.00111	CcSEcCtD
Gliclazide—Weight increased—Citalopram—alcohol dependence	0.00054	0.0011	CcSEcCtD
Gliclazide—Confusional state—Naltrexone—alcohol dependence	0.000537	0.0011	CcSEcCtD
Gliclazide—Hyperglycaemia—Citalopram—alcohol dependence	0.000535	0.00109	CcSEcCtD
Gliclazide—Pneumonia—Citalopram—alcohol dependence	0.000532	0.00109	CcSEcCtD
Gliclazide—Infection—Naltrexone—alcohol dependence	0.000529	0.00108	CcSEcCtD
Gliclazide—Depression—Citalopram—alcohol dependence	0.000527	0.00108	CcSEcCtD
Gliclazide—Hypotension—Acamprosate—alcohol dependence	0.000526	0.00107	CcSEcCtD
Gliclazide—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000524	0.00107	CcSEcCtD
Gliclazide—Nervous system disorder—Naltrexone—alcohol dependence	0.000522	0.00107	CcSEcCtD
Gliclazide—Acute coronary syndrome—Citalopram—alcohol dependence	0.000521	0.00106	CcSEcCtD
Gliclazide—Tachycardia—Naltrexone—alcohol dependence	0.000519	0.00106	CcSEcCtD
Gliclazide—Myocardial infarction—Citalopram—alcohol dependence	0.000518	0.00106	CcSEcCtD
Gliclazide—Neuropathy peripheral—Citalopram—alcohol dependence	0.000518	0.00106	CcSEcCtD
Gliclazide—Skin disorder—Naltrexone—alcohol dependence	0.000517	0.00106	CcSEcCtD
Gliclazide—Jaundice—Citalopram—alcohol dependence	0.000515	0.00105	CcSEcCtD
Gliclazide—Hyperhidrosis—Naltrexone—alcohol dependence	0.000515	0.00105	CcSEcCtD
Gliclazide—Conjunctivitis—Citalopram—alcohol dependence	0.000514	0.00105	CcSEcCtD
Gliclazide—Urinary tract infection—Citalopram—alcohol dependence	0.000514	0.00105	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000513	0.00105	CcSEcCtD
Gliclazide—Insomnia—Acamprosate—alcohol dependence	0.000509	0.00104	CcSEcCtD
Gliclazide—Sweating—Citalopram—alcohol dependence	0.000507	0.00104	CcSEcCtD
Gliclazide—Paraesthesia—Acamprosate—alcohol dependence	0.000505	0.00103	CcSEcCtD
Gliclazide—ABCC8—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000504	0.00507	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000504	0.00507	CbGpPWpGaD
Gliclazide—Dyspnoea—Acamprosate—alcohol dependence	0.000502	0.00102	CcSEcCtD
Gliclazide—Somnolence—Acamprosate—alcohol dependence	0.0005	0.00102	CcSEcCtD
Gliclazide—Hepatobiliary disease—Citalopram—alcohol dependence	0.0005	0.00102	CcSEcCtD
Gliclazide—Epistaxis—Citalopram—alcohol dependence	0.000499	0.00102	CcSEcCtD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000498	0.00501	CbGpPWpGaD
Gliclazide—Sinusitis—Citalopram—alcohol dependence	0.000496	0.00101	CcSEcCtD
Gliclazide—Dyspepsia—Acamprosate—alcohol dependence	0.000495	0.00101	CcSEcCtD
Gliclazide—Agranulocytosis—Citalopram—alcohol dependence	0.000493	0.00101	CcSEcCtD
Gliclazide—CYP2C19—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000487	0.00489	CbGpPWpGaD
Gliclazide—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000486	0.000992	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000485	0.000991	CcSEcCtD
Gliclazide—Bradycardia—Citalopram—alcohol dependence	0.000483	0.000987	CcSEcCtD
Gliclazide—Insomnia—Naltrexone—alcohol dependence	0.000481	0.000984	CcSEcCtD
Gliclazide—Pain—Acamprosate—alcohol dependence	0.000481	0.000983	CcSEcCtD
Gliclazide—Constipation—Acamprosate—alcohol dependence	0.000481	0.000983	CcSEcCtD
Gliclazide—Paraesthesia—Naltrexone—alcohol dependence	0.000478	0.000976	CcSEcCtD
Gliclazide—VEGFA—HIF-1-alpha transcription factor network—EP300—alcohol dependence	0.000476	0.00479	CbGpPWpGaD
Gliclazide—Rhinitis—Citalopram—alcohol dependence	0.000476	0.000972	CcSEcCtD
Gliclazide—Hepatitis—Citalopram—alcohol dependence	0.000475	0.00097	CcSEcCtD
Gliclazide—Dyspnoea—Naltrexone—alcohol dependence	0.000475	0.000969	CcSEcCtD
Gliclazide—Somnolence—Naltrexone—alcohol dependence	0.000473	0.000967	CcSEcCtD
Gliclazide—Hypoaesthesia—Citalopram—alcohol dependence	0.000472	0.000965	CcSEcCtD
Gliclazide—Pharyngitis—Citalopram—alcohol dependence	0.000471	0.000963	CcSEcCtD
Gliclazide—CYP2C19—Biological oxidations—ADH4—alcohol dependence	0.00047	0.00472	CbGpPWpGaD
Gliclazide—Oedema peripheral—Citalopram—alcohol dependence	0.000468	0.000955	CcSEcCtD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000465	0.00467	CbGpPWpGaD
Gliclazide—Feeling abnormal—Acamprosate—alcohol dependence	0.000464	0.000947	CcSEcCtD
Gliclazide—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00046	0.00094	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00046	0.000939	CcSEcCtD
Gliclazide—Fatigue—Naltrexone—alcohol dependence	0.000459	0.000938	CcSEcCtD
Gliclazide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000458	0.00461	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—GRIN2B—alcohol dependence	0.000458	0.0046	CbGpPWpGaD
Gliclazide—Visual impairment—Citalopram—alcohol dependence	0.000457	0.000935	CcSEcCtD
Gliclazide—Pain—Naltrexone—alcohol dependence	0.000455	0.00093	CcSEcCtD
Gliclazide—Constipation—Naltrexone—alcohol dependence	0.000455	0.00093	CcSEcCtD
Gliclazide—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000452	0.00455	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000452	0.00454	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—SLC6A3—alcohol dependence	0.000451	0.00454	CbGpPWpGaD
Gliclazide—Erythema multiforme—Citalopram—alcohol dependence	0.000449	0.000917	CcSEcCtD
Gliclazide—Urticaria—Acamprosate—alcohol dependence	0.000447	0.000913	CcSEcCtD
Gliclazide—Abdominal pain—Acamprosate—alcohol dependence	0.000445	0.000909	CcSEcCtD
Gliclazide—Body temperature increased—Acamprosate—alcohol dependence	0.000445	0.000909	CcSEcCtD
Gliclazide—KCNJ11—Neuronal System—GRIN2B—alcohol dependence	0.000444	0.00446	CbGpPWpGaD
Gliclazide—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000444	0.00446	CbGpPWpGaD
Gliclazide—Eye disorder—Citalopram—alcohol dependence	0.000444	0.000906	CcSEcCtD
Gliclazide—Tinnitus—Citalopram—alcohol dependence	0.000443	0.000904	CcSEcCtD
Gliclazide—Flushing—Citalopram—alcohol dependence	0.000441	0.0009	CcSEcCtD
Gliclazide—Feeling abnormal—Naltrexone—alcohol dependence	0.000439	0.000896	CcSEcCtD
Gliclazide—KCNJ11—Neuronal System—SLC6A3—alcohol dependence	0.000437	0.0044	CbGpPWpGaD
Gliclazide—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000435	0.000889	CcSEcCtD
Gliclazide—ABCC8—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000428	0.00431	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000428	0.00431	CbGpPWpGaD
Gliclazide—Chills—Citalopram—alcohol dependence	0.000426	0.00087	CcSEcCtD
Gliclazide—Arrhythmia—Citalopram—alcohol dependence	0.000424	0.000866	CcSEcCtD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000424	0.00426	CbGpPWpGaD
Gliclazide—Urticaria—Naltrexone—alcohol dependence	0.000423	0.000864	CcSEcCtD
Gliclazide—Body temperature increased—Naltrexone—alcohol dependence	0.000421	0.00086	CcSEcCtD
Gliclazide—Abdominal pain—Naltrexone—alcohol dependence	0.000421	0.00086	CcSEcCtD
Gliclazide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000418	0.0042	CbGpPWpGaD
Gliclazide—Mental disorder—Citalopram—alcohol dependence	0.000416	0.00085	CcSEcCtD
Gliclazide—Hypersensitivity—Acamprosate—alcohol dependence	0.000414	0.000847	CcSEcCtD
Gliclazide—Malnutrition—Citalopram—alcohol dependence	0.000413	0.000844	CcSEcCtD
Gliclazide—Erythema—Citalopram—alcohol dependence	0.000413	0.000844	CcSEcCtD
Gliclazide—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000412	0.00414	CbGpPWpGaD
Gliclazide—Flatulence—Citalopram—alcohol dependence	0.000407	0.000832	CcSEcCtD
Gliclazide—Tension—Citalopram—alcohol dependence	0.000405	0.000828	CcSEcCtD
Gliclazide—Asthenia—Acamprosate—alcohol dependence	0.000404	0.000825	CcSEcCtD
Gliclazide—Nervousness—Citalopram—alcohol dependence	0.000401	0.00082	CcSEcCtD
Gliclazide—Back pain—Citalopram—alcohol dependence	0.0004	0.000817	CcSEcCtD
Gliclazide—CYP2C19—Biological oxidations—ADH7—alcohol dependence	0.000399	0.00402	CbGpPWpGaD
Gliclazide—Pruritus—Acamprosate—alcohol dependence	0.000398	0.000813	CcSEcCtD
Gliclazide—ABCC8—Metabolism—ADH6—alcohol dependence	0.000394	0.00396	CbGpPWpGaD
Gliclazide—Hypersensitivity—Naltrexone—alcohol dependence	0.000392	0.000801	CcSEcCtD
Gliclazide—Tremor—Citalopram—alcohol dependence	0.000387	0.000791	CcSEcCtD
Gliclazide—Diarrhoea—Acamprosate—alcohol dependence	0.000385	0.000786	CcSEcCtD
Gliclazide—Ill-defined disorder—Citalopram—alcohol dependence	0.000383	0.000783	CcSEcCtD
Gliclazide—CYP2C19—Biological oxidations—GGT2—alcohol dependence	0.000383	0.00385	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ADH6—alcohol dependence	0.000382	0.00384	CbGpPWpGaD
Gliclazide—Anaemia—Citalopram—alcohol dependence	0.000382	0.00078	CcSEcCtD
Gliclazide—Asthenia—Naltrexone—alcohol dependence	0.000382	0.00078	CcSEcCtD
Gliclazide—ABCC8—Neuronal System—MAOA—alcohol dependence	0.000381	0.00383	CbGpPWpGaD
Gliclazide—Agitation—Citalopram—alcohol dependence	0.00038	0.000776	CcSEcCtD
Gliclazide—Angioedema—Citalopram—alcohol dependence	0.000378	0.000771	CcSEcCtD
Gliclazide—Pruritus—Naltrexone—alcohol dependence	0.000377	0.000769	CcSEcCtD
Gliclazide—Malaise—Citalopram—alcohol dependence	0.000373	0.000761	CcSEcCtD
Gliclazide—Dizziness—Acamprosate—alcohol dependence	0.000372	0.00076	CcSEcCtD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000371	0.00373	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—GRIN2B—alcohol dependence	0.000371	0.00373	CbGpPWpGaD
Gliclazide—Leukopenia—Citalopram—alcohol dependence	0.00037	0.000756	CcSEcCtD
Gliclazide—KCNJ11—Neuronal System—MAOA—alcohol dependence	0.000369	0.00371	CbGpPWpGaD
Gliclazide—Palpitations—Citalopram—alcohol dependence	0.000365	0.000746	CcSEcCtD
Gliclazide—Diarrhoea—Naltrexone—alcohol dependence	0.000364	0.000744	CcSEcCtD
Gliclazide—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000364	0.00366	CbGpPWpGaD
Gliclazide—Loss of consciousness—Citalopram—alcohol dependence	0.000363	0.000742	CcSEcCtD
Gliclazide—Cough—Citalopram—alcohol dependence	0.000361	0.000737	CcSEcCtD
Gliclazide—Convulsion—Citalopram—alcohol dependence	0.000358	0.000731	CcSEcCtD
Gliclazide—Vomiting—Acamprosate—alcohol dependence	0.000358	0.000731	CcSEcCtD
Gliclazide—Hypertension—Citalopram—alcohol dependence	0.000357	0.000729	CcSEcCtD
Gliclazide—Rash—Acamprosate—alcohol dependence	0.000355	0.000725	CcSEcCtD
Gliclazide—Dermatitis—Acamprosate—alcohol dependence	0.000354	0.000724	CcSEcCtD
Gliclazide—Headache—Acamprosate—alcohol dependence	0.000352	0.00072	CcSEcCtD
Gliclazide—Dizziness—Naltrexone—alcohol dependence	0.000352	0.000719	CcSEcCtD
Gliclazide—Chest pain—Citalopram—alcohol dependence	0.000352	0.000719	CcSEcCtD
Gliclazide—Myalgia—Citalopram—alcohol dependence	0.000352	0.000719	CcSEcCtD
Gliclazide—Arthralgia—Citalopram—alcohol dependence	0.000352	0.000719	CcSEcCtD
Gliclazide—Anxiety—Citalopram—alcohol dependence	0.000351	0.000716	CcSEcCtD
Gliclazide—CYP2C19—Biological oxidations—ADH1B—alcohol dependence	0.00035	0.00352	CbGpPWpGaD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000349	0.000714	CcSEcCtD
Gliclazide—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000349	0.00351	CbGpPWpGaD
Gliclazide—Discomfort—Citalopram—alcohol dependence	0.000348	0.00071	CcSEcCtD
Gliclazide—ALB—Selenium Micronutrient Network—GGT1—alcohol dependence	0.000345	0.00347	CbGpPWpGaD
Gliclazide—Dry mouth—Citalopram—alcohol dependence	0.000344	0.000703	CcSEcCtD
Gliclazide—Confusional state—Citalopram—alcohol dependence	0.00034	0.000695	CcSEcCtD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000339	0.0034	CbGpPWpGaD
Gliclazide—Vomiting—Naltrexone—alcohol dependence	0.000338	0.000691	CcSEcCtD
Gliclazide—Rash—Naltrexone—alcohol dependence	0.000336	0.000686	CcSEcCtD
Gliclazide—Dermatitis—Naltrexone—alcohol dependence	0.000335	0.000685	CcSEcCtD
Gliclazide—Infection—Citalopram—alcohol dependence	0.000335	0.000685	CcSEcCtD
Gliclazide—Nausea—Acamprosate—alcohol dependence	0.000334	0.000683	CcSEcCtD
Gliclazide—Headache—Naltrexone—alcohol dependence	0.000333	0.000681	CcSEcCtD
Gliclazide—Nervous system disorder—Citalopram—alcohol dependence	0.000331	0.000676	CcSEcCtD
Gliclazide—Thrombocytopenia—Citalopram—alcohol dependence	0.00033	0.000675	CcSEcCtD
Gliclazide—Tachycardia—Citalopram—alcohol dependence	0.000329	0.000672	CcSEcCtD
Gliclazide—Skin disorder—Citalopram—alcohol dependence	0.000328	0.000669	CcSEcCtD
Gliclazide—ABCC8—Metabolism—ADH1A—alcohol dependence	0.000326	0.00328	CbGpPWpGaD
Gliclazide—Hyperhidrosis—Citalopram—alcohol dependence	0.000326	0.000666	CcSEcCtD
Gliclazide—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000319	0.00321	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ADH1A—alcohol dependence	0.000317	0.00318	CbGpPWpGaD
Gliclazide—Nausea—Naltrexone—alcohol dependence	0.000316	0.000646	CcSEcCtD
Gliclazide—Hypotension—Citalopram—alcohol dependence	0.000315	0.000644	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000307	0.000628	CcSEcCtD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000306	0.00307	CbGpPWpGaD
Gliclazide—Insomnia—Citalopram—alcohol dependence	0.000305	0.000623	CcSEcCtD
Gliclazide—Paraesthesia—Citalopram—alcohol dependence	0.000303	0.000619	CcSEcCtD
Gliclazide—Dyspnoea—Citalopram—alcohol dependence	0.000301	0.000614	CcSEcCtD
Gliclazide—Somnolence—Citalopram—alcohol dependence	0.0003	0.000613	CcSEcCtD
Gliclazide—Dyspepsia—Citalopram—alcohol dependence	0.000297	0.000607	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000291	0.000595	CcSEcCtD
Gliclazide—Fatigue—Citalopram—alcohol dependence	0.000291	0.000594	CcSEcCtD
Gliclazide—CYP2C19—Biological oxidations—MAOB—alcohol dependence	0.00029	0.00292	CbGpPWpGaD
Gliclazide—Pain—Citalopram—alcohol dependence	0.000288	0.000589	CcSEcCtD
Gliclazide—Constipation—Citalopram—alcohol dependence	0.000288	0.000589	CcSEcCtD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000279	0.0028	CbGpPWpGaD
Gliclazide—Feeling abnormal—Citalopram—alcohol dependence	0.000278	0.000568	CcSEcCtD
Gliclazide—ABCC8—Metabolism—ADH4—alcohol dependence	0.000278	0.00279	CbGpPWpGaD
Gliclazide—Gastrointestinal pain—Citalopram—alcohol dependence	0.000276	0.000563	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—ADH4—alcohol dependence	0.000269	0.00271	CbGpPWpGaD
Gliclazide—Urticaria—Citalopram—alcohol dependence	0.000268	0.000547	CcSEcCtD
Gliclazide—Body temperature increased—Citalopram—alcohol dependence	0.000267	0.000545	CcSEcCtD
Gliclazide—Abdominal pain—Citalopram—alcohol dependence	0.000267	0.000545	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—GRIN2B—alcohol dependence	0.000265	0.00266	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000265	0.00266	CbGpPWpGaD
Gliclazide—Hypersensitivity—Citalopram—alcohol dependence	0.000248	0.000508	CcSEcCtD
Gliclazide—CYP2C19—Biological oxidations—ALDH2—alcohol dependence	0.000247	0.00248	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.000246	0.00247	CbGpPWpGaD
Gliclazide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000245	0.00247	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000242	0.00244	CbGpPWpGaD
Gliclazide—Asthenia—Citalopram—alcohol dependence	0.000242	0.000494	CcSEcCtD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—EP300—alcohol dependence	0.000239	0.00241	CbGpPWpGaD
Gliclazide—Pruritus—Citalopram—alcohol dependence	0.000239	0.000487	CcSEcCtD
Gliclazide—ABCC8—Metabolism—ADH7—alcohol dependence	0.000236	0.00237	CbGpPWpGaD
Gliclazide—Diarrhoea—Citalopram—alcohol dependence	0.000231	0.000471	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—ADH7—alcohol dependence	0.000229	0.0023	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—OPRK1—alcohol dependence	0.000228	0.00229	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GGT2—alcohol dependence	0.000226	0.00228	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.000225	0.00226	CbGpPWpGaD
Gliclazide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000224	0.00225	CbGpPWpGaD
Gliclazide—Dizziness—Citalopram—alcohol dependence	0.000223	0.000456	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—GGT2—alcohol dependence	0.000219	0.00221	CbGpPWpGaD
Gliclazide—Vomiting—Citalopram—alcohol dependence	0.000214	0.000438	CcSEcCtD
Gliclazide—Rash—Citalopram—alcohol dependence	0.000213	0.000434	CcSEcCtD
Gliclazide—Dermatitis—Citalopram—alcohol dependence	0.000212	0.000434	CcSEcCtD
Gliclazide—Headache—Citalopram—alcohol dependence	0.000211	0.000432	CcSEcCtD
Gliclazide—ABCC8—Metabolism—ADH1B—alcohol dependence	0.000207	0.00208	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000203	0.00205	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ADH1B—alcohol dependence	0.000201	0.00202	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000201	0.00202	CbGpPWpGaD
Gliclazide—Nausea—Citalopram—alcohol dependence	0.0002	0.000409	CcSEcCtD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000199	0.002	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—CYP2E1—alcohol dependence	0.000197	0.00198	CbGpPWpGaD
Gliclazide—CYP2C19—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000195	0.00196	CbGpPWpGaD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000181	0.00182	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—GGT1—alcohol dependence	0.000181	0.00182	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.00018	0.00181	CbGpPWpGaD
Gliclazide—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000177	0.00178	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—MAOB—alcohol dependence	0.000171	0.00172	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—MAOB—alcohol dependence	0.000166	0.00167	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.000165	0.00166	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000162	0.00163	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—MAOA—alcohol dependence	0.000162	0.00163	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—EP300—alcohol dependence	0.000157	0.00158	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000154	0.00155	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—OPRD1—alcohol dependence	0.000153	0.00154	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—MAOA—alcohol dependence	0.000148	0.00149	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PDYN—alcohol dependence	0.000147	0.00148	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ALDH2—alcohol dependence	0.000146	0.00147	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ALDH2—alcohol dependence	0.000141	0.00142	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000138	0.00139	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—WASF2—alcohol dependence	0.000137	0.00137	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CRHR1—alcohol dependence	0.000137	0.00137	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—WASF1—alcohol dependence	0.000131	0.00132	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CHRM2—alcohol dependence	0.000128	0.00129	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000127	0.00128	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ADH6—alcohol dependence	0.000127	0.00128	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GOT2—alcohol dependence	0.000124	0.00125	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GOT2—alcohol dependence	0.00012	0.00121	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—OPRM1—alcohol dependence	0.000118	0.00119	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CYP2E1—alcohol dependence	0.000117	0.00117	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ADH6—alcohol dependence	0.000114	0.00115	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CYP2E1—alcohol dependence	0.000113	0.00114	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NPY—alcohol dependence	0.000109	0.00109	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GGT1—alcohol dependence	0.000107	0.00108	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GOT1—alcohol dependence	0.000107	0.00108	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—POMC—alcohol dependence	0.000106	0.00106	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ADH1A—alcohol dependence	0.000105	0.00106	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR1B—alcohol dependence	0.000105	0.00105	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CRH—alcohol dependence	0.000105	0.00105	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ADH6—alcohol dependence	0.000104	0.00105	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GGT1—alcohol dependence	0.000104	0.00104	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GOT1—alcohol dependence	0.000104	0.00104	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—POMC—alcohol dependence	9.63e-05	0.000969	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—MAOA—alcohol dependence	9.59e-05	0.000964	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—EP300—alcohol dependence	9.51e-05	0.000957	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ADH1A—alcohol dependence	9.45e-05	0.00095	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—EP300—alcohol dependence	9.33e-05	0.000938	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—MAOA—alcohol dependence	9.3e-05	0.000935	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—DRD4—alcohol dependence	9.15e-05	0.00092	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ADH4—alcohol dependence	8.95e-05	0.0009	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CNR1—alcohol dependence	8.74e-05	0.000879	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ADH1A—alcohol dependence	8.61e-05	0.000866	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR7—alcohol dependence	8.53e-05	0.000857	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—DRD2—alcohol dependence	8.53e-05	0.000857	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ADH4—alcohol dependence	8.03e-05	0.000808	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	7.82e-05	0.000786	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	7.75e-05	0.000779	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ADH7—alcohol dependence	7.61e-05	0.000765	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ADH4—alcohol dependence	7.32e-05	0.000737	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GGT2—alcohol dependence	7.29e-05	0.000734	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AVP—alcohol dependence	7.18e-05	0.000722	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	6.95e-05	0.000699	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ADH7—alcohol dependence	6.83e-05	0.000687	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ADH1B—alcohol dependence	6.67e-05	0.000671	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GGT2—alcohol dependence	6.55e-05	0.000658	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—AVP—alcohol dependence	6.47e-05	0.00065	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	6.34e-05	0.000638	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—POMC—alcohol dependence	6.24e-05	0.000628	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ADH7—alcohol dependence	6.23e-05	0.000626	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—POMC—alcohol dependence	6.05e-05	0.000609	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ADH1B—alcohol dependence	5.99e-05	0.000602	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR2A—alcohol dependence	5.97e-05	0.000601	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GGT2—alcohol dependence	5.97e-05	0.0006	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MAOB—alcohol dependence	5.53e-05	0.000556	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ADH1B—alcohol dependence	5.46e-05	0.000549	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MAOB—alcohol dependence	4.96e-05	0.000499	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—POMC—alcohol dependence	4.77e-05	0.00048	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ALDH2—alcohol dependence	4.7e-05	0.000473	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MAOB—alcohol dependence	4.53e-05	0.000455	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.52e-05	0.000455	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALDH2—alcohol dependence	4.22e-05	0.000424	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—EP300—alcohol dependence	4.14e-05	0.000416	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.06e-05	0.000408	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—EP300—alcohol dependence	4.02e-05	0.000404	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GOT2—alcohol dependence	4e-05	0.000402	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALDH2—alcohol dependence	3.85e-05	0.000387	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP2E1—alcohol dependence	3.76e-05	0.000378	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.7e-05	0.000372	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GOT2—alcohol dependence	3.59e-05	0.000361	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GGT1—alcohol dependence	3.45e-05	0.000347	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GOT1—alcohol dependence	3.45e-05	0.000347	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP2E1—alcohol dependence	3.37e-05	0.000339	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—EP300—alcohol dependence	3.29e-05	0.000331	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GOT2—alcohol dependence	3.27e-05	0.000329	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EP300—alcohol dependence	3.16e-05	0.000318	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GGT1—alcohol dependence	3.1e-05	0.000311	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GOT1—alcohol dependence	3.1e-05	0.000311	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MAOA—alcohol dependence	3.09e-05	0.000311	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP2E1—alcohol dependence	3.08e-05	0.000309	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3e-05	0.000302	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GGT1—alcohol dependence	2.82e-05	0.000284	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GOT1—alcohol dependence	2.82e-05	0.000284	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MAOA—alcohol dependence	2.78e-05	0.000279	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.69e-05	0.000271	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MAOA—alcohol dependence	2.53e-05	0.000254	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.45e-05	0.000247	CbGpPWpGaD
Gliclazide—ALB—Metabolism—POMC—alcohol dependence	2.01e-05	0.000202	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—POMC—alcohol dependence	1.81e-05	0.000182	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—POMC—alcohol dependence	1.65e-05	0.000166	CbGpPWpGaD
Gliclazide—ALB—Metabolism—EP300—alcohol dependence	1.34e-05	0.000134	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—EP300—alcohol dependence	1.2e-05	0.000121	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—EP300—alcohol dependence	1.09e-05	0.00011	CbGpPWpGaD
